Characteristics of the COVID-19 epidemic process in the Volga Federal District in 2020–2023
https://doi.org/10.22328/2077-9828-2024-16-4-117-127
Abstract
The aim of the study was to determine characteristics of COVID-19 epidemic process in the Volga federal district in 2020–2023.
Materials and methods. Analysis of the COVID-19 epidemic process progress was carried out from March 30, 2020 to December 31, 2023. We used information from the website «report.gsen.ru», materials from the national platform for the aggregation of SARS-CoV-2 genome data — VGARus, the official website of Rospotrebnadzor, the information portal Stopcoronavirus rf, data from the official World Health Organization (WHO) website, weekly reports submitted by the Rospotrebnadzor of the subjects of the Volga Federal District.
Results and discussion. The average district incidence rate of a new coronavirus infection was 1280.70/0000 in 2020, 3863.00/0000 in 2021, 7352.20/0000 in 2022, 1398.30/0000 in 2023. In the period from 2020 to 2023, the prevalence of persons aged 30–49 years and 50–64 years in the structure of COVID-19 cases was recorded. The largest proportion of severe cases was recorded in 2022 and 2023 (58.8% and 57.9%, respectively), the smallest — in 2020 (37.6%). The average district mortality and lethality rates were — 20.60/0000 and 1.6% in 2020, 150.80/0000 and 3.9% in 2022, 46.90/0000 and 0.6% in 2022, 3.00/0000 and 0.2% in 2023 respectively.
Conclusion. In the period 2020–2023, the COVID-19 incidence rate in general in the Volga Federal District varied, there was an increase in the proportion of mild severe cases, as well as a decrease in mortality and lethality rates, which is associated with a change in circulatingSARS-CoV-2 genovariants, the formation of population immunity, and the organization of a comprehensive system of anti-epidemic measures.
About the Authors
I. N. Tuzova
Academician I.N. Blokhina Nizhny Novgorod Scientific Research Institute of Epidemiology and Microbiology
Russian Federation
Russian Federation
Nizhny Novgorod
S. A. Sarskov
Academician I.N. Blokhina Nizhny Novgorod Scientific Research Institute of Epidemiology and Microbiology
Russian Federation
Russian Federation
Nizhny Novgorod
E. E. Kuzovatova
Academician I.N. Blokhina Nizhny Novgorod Scientific Research Institute of Epidemiology and Microbiology
Russian Federation
Russian Federation
Nizhny Novgorod
A. V. Polyanina
Academician I.N. Blokhina Nizhny Novgorod Scientific Research Institute of Epidemiology and Microbiology
Russian Federation
Russian Federation
Nizhny Novgorod
N. N. Zaitseva
Academician I.N. Blokhina Nizhny Novgorod Scientific Research Institute of Epidemiology and Microbiology
Russian Federation
Russian Federation
Nizhny Novgorod
References
1. Belyakov N.A., Bagnenko S.F., Rassokhin V.V., Trofimova T.N. et al. The evolution of the COVID-19 pandemic: a monograph. St. Petersburg: Baltic Medical Educational Center, 2021. 410 p.: ill (In Russ.)].
2. Cucinotta D., Vanelli M. WHO Declares COVID-19 a Pandemic // Acta Biomed. 2020. Vol. 91, No. 1. P. 157–160. doi: 10.23750/abm.v91i1.9397.
3. Wettstein L., Kirchhoff F., Münch J. The Transmembrane Protease TMPRSS2 as a Therapeutic Target for COVID-19 Treatment // National Library of Medecine. 2022. Vol. 23, No. 3. P. 1351. doi: 10.3390/ijms23031351.
4. Akimkin V.G., Popova A.Y., Ploskireva A.A. et al. COVID-19: the evolution of the pandemic in Russia. Report I: manifestations of the COVID-19 epidemic process. Journal of microbiology, epidemiology and immunobiology, 2022, Vol. 99, No. 3, рр. 269–286 (In Russ.)]. doi: https://doi.org/10.36233/0372-9311-276.
5. Akimkin V.G., Popova A.Y., Khafizov K.F. et al. COVID-19: evolution of the pandemic in Russia. Report II: dynamics of the circulation of SARS-CoV-2 genetic variants. Journal of microbiology, epidemiology and immunobiology, 2022, Vol. 99, No. 3, рр. 381–396 (In Russ.)]. doi: https://doi.org/10.36233/0372-9311-276.
6. Bolevich S.B., Bolevich S.S. Complex mechanism of COVID-19 development. Sechenovsky Bulletin, 2020, Vol. 11, No. 2, рр. 50–61 (In Russ.)]. doi: 10.47093/2218-7332.2020.11.2.50-61.
7. Kutyrev V.V., Popova A.Yu., Smolensky V.Yu. et al. Epidemiological Features of New Coronavirus Infection (COVID-19). Communication 1: Modes of Implementation of Preventive and Anti-epidemic Measure. Problems of particularly dangerous infections, 2020, No. 1, рр. 6–13 (In Russ.)]. doi: 10.21055/0370-1069-2020-1-6-13.
8. Akimkin V.G., Kuzin S.N., Semenenko T.A., Shipulina O.Y., Yatsyshina S.B., Tivanova E.V. et al. Patterns of the SARS-CoV-2 epidemic spread in a megacity. Problems of Virology, 2020, Vol. 65, No. 4. P. 203–211 (In Russ.)]. doi: 10.36233/0507-4088-2020-65-4-203-211.
9. Vechorko V.I., Averkov O.V., Zimin A.A. New SARS-CoV-2 Omicron variant — clinical picture, treatment, prevention (literature review). Cardiovascular Therapy and Prevention, 2022, Vol. 21, No. 6, рр. 89–98 (In Russ.)]. doi: 10.15829/1728-8800-2022-3228.
10. Akimkin V.G. Epidemiology and diagnosis of COVID-19. Monitoring of the evolutionary changes of the SARS-CoV-2 virus. Bulletin of the Russian Academy of Sciences, 2022, Vol. 7, рр. 647–653 (In Russ.)]. doi: 10.31857/S0869587322070027.
11. Zaitseva N.V., Klein S.V., Glukhikh M.V. Spatial and dynamic heterogeneity of the course of the COVID-19 epidemic process in the subjects of the Russian Federation (2020–2023). Health risk analysis, 2023, Vol. 2, No. 42, рр. 4–16 (In Russ.)]. doi: 10.21668/health.risk/2023.2.01.
12. Kuznetsova N.A., Ogarkova D.A., Gushchin V.A. et al. Evaluation of the dynamics of detection of viable SARS-CoV-2 (Coronaviridae: Betacoronavirus: Sarbecovirus) in biological samples obtained from patients with COVID-19 in a health care setting, as one of the indicators of the infectivity of the virus. Problems of Virology, 2023, Vol. 68, No. 2, рр. 105–116 (In Russ.)]. doi: 10.36233/0507-4088-160.
13. Akimkin V.G., Kuzin S.N., Semenenko T.A. et al. Characteristics of the COVID-19 Epidemiological Situation in the Russian Federation in 2020. Annals of the Russian academy of medical sciences, 2021, Vol. 76, No. 4, рр. 412–422 (In Russ.)]. doi: 10.15690/vramn1505.
14. Pshenichnaya N.Yu., Lizinfeld I.A., Zhuravlev G.Yu. et al. The epidemic process of COVID-19 in the Russian Federation: interim results. Message 1. Infectious diseases, 2020, Vol. 18, No. 3, рр. 7–14 (In Russ.)]. doi: 10.20953/1729-9225-2020-3-7-14.
15. Pshenichnaya N.Yu., Lizinfeld I.A., Zhuravlev G.Yu. et al. The epidemic process of COVID-19 in the Russian Federation: interim results. Message 2. Infectious diseases, 2021, Vol. 19, No. 1, рр. 10–15 (In Russ.)]. doi: 10.20953/1729-9225-2021-1-10-15.
16. Lazareva M.A., Evseeva G.P., Suprun S.V., Lebed’ko O.A. Some features of the transmission of COVID-19 infection in the child population (review). Bulletin Physiology and Pathology of Respiration, 2022, Vol. 83, No. 119–131 (In Russ.)]. doi: 10.36604/1998-5029-2022-83-119-131.
17. Gorelov A.V., Ploskireva A.A., Muzyka A.D. Evolution of clinical and pathogenetic features of COVID-19 coronavirus infection. Russian Medical Journal. Medical Review, 2022, Vol. 6, No. 11, рр. 626–634 (In Russ.)]. doi: 10.32364/2587-6821-2022-6-11-626-634.
18. Baklaushev V.P., Yusubalieva G.M., Bychinin M.V., Yusubalieva S.M., Kalsin V.A., Troitskiy A.V. A rational strategy for the maintenance of antiviral immunity to new SARS-CoV-2 strains. Journal of Clinical Practice, 2022, Vol. 13, No. 3, рр. 43–55 (In Russ.)]. doi: https: // doi.org/10.17816/clinpract111120.
Review
For citations:
Tuzova I.N., Sarskov S.A., Kuzovatova E.E., Polyanina A.V., Zaitseva N.N. Characteristics of the COVID-19 epidemic process in the Volga Federal District in 2020–2023. HIV Infection and Immunosuppressive Disorders. 2024;16(4):117-127. (In Russ.) https://doi.org/10.22328/2077-9828-2024-16-4-117-127
Views:
139
.png)
Email this article 